Real-world evidence in achondroplasia: considerations for a standardized data set.
Yasemin AlanayKlaus MohnikeOla NilssonInês AlvesMoeenaldeen AlSayedNatasha M Appelman-DijkstraGenevieve BaujatTawfeg Ben-OmranSandra BreyerValerie Cormier-DairePernille Axél GregersenEncarna Guillén-NavarroWolfgang HöglerMohamad MaghnieSwati MukherjeeShelda CohenJeanne PimentaAngelo SelicorniJ Oliver SemlerSabine SigaudyDmitry PopkovIan SabirSusana NovalMarco SessaMelita IrvingPublished in: Orphanet journal of rare diseases (2023)
Long-term, high-quality data are needed for this rare, multifaceted condition. Establishing registries that collect predefined data elements across age spans will provide contemporaneous prospective and longitudinal information and will be useful to improve clinical decision-making and management. It should be feasible to collect a minimum dataset with the flexibility to include country-specific criteria and pool data across countries to examine clinical outcomes associated with achondroplasia and different therapeutic approaches.